European Organisation For Research And Treatment Of Cancer - Eortc

This study is testing if adding a precise, high-dose radiation treatment (SABR) to the standard immunotherapy drug pembrolizumab works better than the drug alone for controlling advanced head and neck cancer that has spread to a few other body sites. It will enroll 200 adults who…

This study is testing if taking a daily pill called vorasidenib can help keep a specific type of brain tumor (IDH-mutant astrocytoma) from growing or coming back after patients finish their initial chemotherapy and radiation. It will involve about 468 adults who have completed th…

This large, phase 3 trial is testing if men with advanced prostate cancer can safely take breaks from their continuous hormone-blocking therapy. The goal is to see if stopping treatment when the cancer is well-controlled can significantly improve patients' quality of life—reducin…

This study aims to find a better treatment for glioblastoma, an aggressive brain cancer, when it returns after initial therapy. It will compare the standard chemotherapy drug, lomustine, alone versus lomustine combined with a second course of radiation therapy. The goal is to see…

This study is testing if continuing an immunotherapy drug called cemiplimab for up to a year helps people with a specific type of advanced lung cancer live longer without their cancer getting worse. It's for patients whose cancer has spread to only a few other sites in the body a…

This study tests whether a drug called tebentafusp can prevent cancer from returning in people with high-risk eye melanoma after their initial treatment. About 290 patients who have completed treatment for their primary eye tumor will be randomly assigned to either receive the dr…

This trial is testing a new, targeted radiation treatment for adults with recurrent meningioma, a type of brain tumor that has returned after surgery and radiation. The treatment uses a radioactive drug that seeks out and delivers radiation directly to tumor cells. Researchers wi…

This study is collecting information on people with various types of brain tumors to see if a new, more detailed way of classifying them helps doctors choose better treatments and predict outcomes more accurately. It will follow about 1,650 patients for up to five years to compar…